PMH5 COST-EFFECTIVENESS OF RISPERIDONE LONG-ACTING INJECTABLE VERSUS QUETIAPINE IN SCHIZOPHRENIC PATIENTS
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75472-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)75472-3/fulltext
Title :
PMH5 COST-EFFECTIVENESS OF RISPERIDONE LONG-ACTING INJECTABLE VERSUS QUETIAPINE IN SCHIZOPHRENIC PATIENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75472-3&doi=10.1016/S1098-3015(10)75472-3
First page :
Section Title :
Open access? :
No
Section Order :
1400